Dezhan Healthcare Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Wei Liu

Geschäftsführender

CN¥4.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	7.7yrs
Eigentum des Geschäftsführers	0.2%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	2.8yrs

Jüngste Management Updates

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18

Geschäftsführer

Wei Liu (54 yo)

7.7yrs

Amtszeit

CN¥3,980,000

Vergütung

Mr. Wei Liu is Co-Chairman & GM of Dezhan Healthcare Company Limited from October 28, 2016.

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Wei Liu	Co-Chairman & GM	7.7yrs	CN¥3.98m	0.23% CN¥ 10.2m
Weihong Sun	Independent Director	2.8yrs	CN¥180.00k	keine Daten
Bin Wu	Independent Director	2.8yrs	CN¥180.00k	keine Daten
Hailin Yan	Non-Independent Director	2.8yrs	keine Daten	keine Daten
Zheming Wei	Chairman	7.7yrs	keine Daten	0.021% CN¥ 936.2k
Feng Han	Director	2.1yrs	keine Daten	keine Daten
Sinian Chou	Non-Independent Director	2.8yrs	CN¥60.00k	keine Daten
Xin An Wang	Independent Director	2.8yrs	keine Daten	keine Daten
Ping Li	Employee Supervisor	2.8yrs	keine Daten	keine Daten

2.8yrs

Durchschnittliche Betriebszugehörigkeit

54yo

Durchschnittliches Alter

Erfahrener Vorstand: 000813Die Vorstandsmitglieder gelten nicht als erfahren ( 2.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.

Dezhan Healthcare Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Recent updates

Dezhan Healthcare Company Limited to Report First Half, 2024 Results on Aug 28, 2024

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Full year 2023 earnings released: EPS: CN¥0.038 (vs CN¥0.021 loss in FY 2022)

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

Dezhan Healthcare Company Limited to Report Q1, 2024 Results on Apr 25, 2024

Dezhan Healthcare Company Limited to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0 in 3Q 2022)

Dezhan Healthcare Company Limited to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.016 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.014 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0 (vs CN¥0.01 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.017 in 2Q 2021)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.017 (vs CN¥0.041 in 2Q 2020)

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

Dezhan Healthcare Company Limited Announces the Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.041 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥3.98

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.85

Dezhan Healthcare's Controlling Shareholder Plans to Sell Stake in the Company

New 90-day high: CN¥6.85

Third quarter earnings released

New 90-day low: CN¥6.05

First half earnings released

Dezhan Healthcare Company Limited to Report First Half, 2020 Results on Aug 29, 2020

Dezhan Healthcare Company Limited (SZSE:000813) completed the acquisition of 70% stake in Beijing Changjiang Mai Medical Technology Co., Ltd from Dai Yanzhen.